New study shows AI detects ovarian cancer more accurately than human experts

For the approximately 20,000 women in the U.S. who receive treatment; Diagnosis of ovarian cancer Artificial intelligence emerges every year as a potentially life-saving tool.

A new study led by researchers at Sweden's Karolinska Institute AI model They were better at detecting ovarian cancer than human doctors.

The study, published in Nature Medicine, tested the ability of an AI model to distinguish between benign and malignant lesions of the ovary, according to a press release.

The AI ​​model was trained on more than 17,000 ultrasound images from 3,652 patients from 20 hospitals in eight countries, according to the release.

The AI ​​model achieved 86% accuracy. Ovarian cancer detection82% for human experts and 77% for non-experts.

Trish Bailey, Jean Kitson, Natasha Stott D'Esposia and Nicole Graney meet ambassadors and others at the Sydney Opera House ahead of the lighting of the Teal Ribbon Day sails to honor women who have lost their battles with ovarian cancer. He met up with the survivors.

“We were surprised that the AI ​​model outperformed all 33 expert judges,” study author Elizabeth Epstein, a professor in the Department of Clinical Sciences and Education at Karolinska Institutet, told FOX News Digital.

Parents trust AI for medical advice more than doctors, researchers find

Epstein said ovarian tumors are common and “often discovered incidentally.”

“Our research Diagnostic support using AI “By increasing triage efficiency, reducing diagnostic errors, and addressing the shortage of specialized examiners, we can significantly improve ovarian cancer diagnosis,” she said in a statement to Fox News Digital.

“High-quality diagnostics could become more accessible, especially in areas where access to experienced medical examiners is limited,” Epstein continued.

“This reduces waiting times, avoids unnecessary interventions, promotes early detection of cancer, and ultimately improves symptoms.” patient outcome and ensures more accurate diagnosis. ”

AI may also reduce the need for referrals and the chance of misdiagnosis, the researchers noted.

Dr. Brian Slomowitz, director of gynecologic oncology at Mount Sinai Medical Center in Florida and co-chair of the Committee on Cancer Research, said screening and early detection of ovarian cancer can help reduce deaths from the disease. “The Holy Grail,” he said.

Ovarian cancer treatment is on track for FDA approval as chemotherapy alternatives emerge: 'We're making progress'

“This large retrospective study clearly shows that there may be a role for incorporating AI-driven support to better interpret ultrasound findings in patients with pelvic masses.” , Slomowitz, who was not involved in this particular study, told FOX News Digital.

“This in itself increases the accuracy of radiological findings by reducing both the false-positive rate (leading to unnecessary surgery) and the false-negative rate (missing cancer).”

There are other evaluation methods ovarian cancer patient The doctor pointed out that this goes beyond a radiological examination.

“Menopausal status, presence of symptoms, and blood test results are also some of the factors used to determine which patients require surgery,” Slomowitz said. “It would be great to be able to incorporate these elements into AI modeling.”

Ovarian Cancer Signs, Symptoms, Diagnosis and Treatment Options

He added that for AI technology to be widely used, it needs to not only show improved accuracy in ultrasound analysis, but also demonstrate survival benefits.

“I am optimistic that artificial intelligence will become part of the arsenal used to improve the care we provide to patients.”

Dr. Harvey Castro Based in Dallas, Texas The board-certified emergency medicine physician and national speaker on AI in healthcare agreed that the technology has the potential to improve cancer diagnosis, but warned that limitations remain.

“AI relies on diverse, high-quality data, and bias can limit its effectiveness,” he told FOX News Digital.

“It has also not been fully validated for routine clinical use, and transparency and regulatory concerns remain unresolved.”

Mr. Castro reiterated that additional research It is needed to determine how well AI adapts to real-world situations, its long-term impact on healthcare costs and outcomes, and whether the technology can accommodate diverse populations and different clinical settings.

For more health articles, visit: www.foxnews.com/health

The researchers also acknowledged potential limitations of the study.

“This is not a prospective study, so we need additional data to know how it will perform in a real-world clinical setting,” Epstein told Fox News Digital.

She added that the team plans to begin clinical research soon at Stockholm South Hospital in Sweden.

Epstein pointed out that AI should only be used as diagnostic support and not as a replacement for human doctors.

“Physicians are still responsible for the treatment of patients. diagnosis and treatment” she said.

CLICK HERE TO GET THE FOX NEWS APP

The Karolinska Institute research team collaborated with KTH Royal Institute of Technology. Funding was provided by the Swedish Research Council, the Swedish Cancer Society, the Stockholm Regional Council, the Radium Hemet Cancer Research Fund, and Wallenberg AI, Autonomous Systems and Software Programs (WASP), according to the release.

Read the rest of this story FOX News.